Morgan Stanley assumed coverage of Palantir with an Underweight rating and $60 price target. Palantir’s commercial traction and Artificial Intelligence Platform product cycle drove a multiple re-rating, while the government segment and spending discipline drove upside to estimates, the analyst tells investors in a research note. However, the firm sees the company’s success as “more than priced in at the current multiple premium.” It sees near-term risks around the incoming administration and government news flow “as reasons why dislocation might sustain near term.”